These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 31179332)
21. Childhood onset homozygous recessive GDAP1 (p.Pro231Leu) mutation in a 9-year-old puerto rican pediatric female with axonal Charcot-Marie-Tooth disease: A case report. Ortiz-Santiago A; Ramos E J Pediatr Rehabil Med; 2021; 14(3):533-537. PubMed ID: 34057104 [TBL] [Abstract][Full Text] [Related]
22. Two recessive intermediate Charcot-Marie-Tooth patients with GDAP1 mutations. Chung KW; Hyun YS; Lee HJ; Jung HK; Koo H; Yoo JH; Kim SB; Park CI; Kim HN; Choi BO J Peripher Nerv Syst; 2011 Jun; 16(2):143-6. PubMed ID: 21692914 [TBL] [Abstract][Full Text] [Related]
23. A new missense GDAP1 mutation disturbing targeting to the mitochondrial membrane causes a severe form of AR-CMT2C disease. Kabzińska D; Niemann A; Drac H; Huber N; Potulska-Chromik A; Hausmanowa-Petrusewicz I; Suter U; Kochański A Neurogenetics; 2011 May; 12(2):145-53. PubMed ID: 21365284 [TBL] [Abstract][Full Text] [Related]
24. Phenotypical features of the p.R120W mutation in the GDAP1 gene causing autosomal dominant Charcot-Marie-Tooth disease. Sivera R; Espinós C; Vílchez JJ; Mas F; Martínez-Rubio D; Chumillas MJ; Mayordomo F; Muelas N; Bataller L; Palau F; Sevilla T J Peripher Nerv Syst; 2010 Dec; 15(4):334-44. PubMed ID: 21199105 [TBL] [Abstract][Full Text] [Related]
25. Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy. Nelis E; Erdem S; Van Den Bergh PY; Belpaire-Dethiou MC; Ceuterick C; Van Gerwen V; Cuesta A; Pedrola L; Palau F; Gabreëls-Festen AA; Verellen C; Tan E; Demirci M; Van Broeckhoven C; De Jonghe P; Topaloglu H; Timmerman V Neurology; 2002 Dec; 59(12):1865-72. PubMed ID: 12499475 [TBL] [Abstract][Full Text] [Related]
26. Two novel mutations in the GDAP1 and PRX genes in early onset Charcot-Marie-Tooth syndrome. Auer-Grumbach M; Fischer C; Papić L; John E; Plecko B; Bittner RE; Bernert G; Pieber TR; Miltenberger G; Schwarz R; Windpassinger C; Grill F; Timmerman V; Speicher MR; Janecke AR Neuropediatrics; 2008 Feb; 39(1):33-8. PubMed ID: 18504680 [TBL] [Abstract][Full Text] [Related]
27. A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations. Vital A; Latour P; Sole G; Ferrer X; Rouanet M; Tison F; Vital C; Goizet C Neuromuscul Disord; 2012 Aug; 22(8):735-41. PubMed ID: 22546700 [TBL] [Abstract][Full Text] [Related]
28. Case report: exome sequencing achieved a definite diagnosis in a Chinese family with muscle atrophy. Jiang H; Guo C; Xie J; Pan J; Huang Y; Li M; Guo Y BMC Neurol; 2021 Mar; 21(1):96. PubMed ID: 33653295 [TBL] [Abstract][Full Text] [Related]
29. A novel Met116Thr mutation in the GDAP1 gene in a Polish family with the axonal recessive Charcot-Marie-Tooth type 4 disease. Kabzińska D; Kochański A; Drac H; Rowińska-Marcińska K; Ryniewicz B; Pedrola L; Palau F; Hausmanowa-Petrusewicz I J Neurol Sci; 2006 Feb; 241(1-2):7-11. PubMed ID: 16343542 [TBL] [Abstract][Full Text] [Related]
30. [Identification of a novel c.1A>G variant of GDAP1 gene in a pedigree affected with autosomal recessive fibula atrophy]. Liu C; Yan Y; Zhao J; Ha L; Xu X Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Nov; 37(11):1244-1246. PubMed ID: 33179230 [TBL] [Abstract][Full Text] [Related]
31. The GST domain of GDAP1 is a frequent target of mutations in the dominant form of axonal Charcot Marie Tooth type 2K. Crimella C; Tonelli A; Airoldi G; Baschirotto C; D'Angelo MG; Bonato S; Losito L; Trabacca A; Bresolin N; Bassi MT J Med Genet; 2010 Oct; 47(10):712-6. PubMed ID: 20685671 [TBL] [Abstract][Full Text] [Related]
32. [Analysis of Qin L; Yang C; Lü T; Li L; Zong D; Wu Y Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jan; 39(1):63-68. PubMed ID: 30692068 [TBL] [Abstract][Full Text] [Related]
33. Phenotypical features of a new dominant GDAP1 pathogenic variant (p.R226del) in axonal Charcot-Marie-Tooth disease. García-Sobrino T; Blanco-Arias P; Palau F; Espinós C; Ramirez L; Estela A; San Millán B; Arias M; Sobrido MJ; Pardo J Neuromuscul Disord; 2017 Jul; 27(7):667-672. PubMed ID: 28236508 [TBL] [Abstract][Full Text] [Related]
34. Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene. Azzedine H; Ruberg M; Ente D; Gilardeau C; Périé S; Wechsler B; Brice A; LeGuern E; Dubourg O Neuromuscul Disord; 2003 May; 13(4):341-6. PubMed ID: 12868504 [TBL] [Abstract][Full Text] [Related]
35. Phenotype of Charcot-Marie-Tooth disease Type 2. Bienfait HM; Baas F; Koelman JH; de Haan RJ; van Engelen BG; Gabreëls-Festen AA; Ongerboer de Visser BW; Meggouh F; Weterman MA; De Jonghe P; Timmerman V; de Visser M Neurology; 2007 May; 68(20):1658-67. PubMed ID: 17502546 [TBL] [Abstract][Full Text] [Related]
36. Clinical and molecular evidence of possible digenic inheritance for MFN2/GDAP1 genes in Charcot-Marie-Tooth disease. Barreda Fierro R; Herrera Mora P; Zenteno JC; Villarroel Cortés CE Neuromuscul Disord; 2020 Dec; 30(12):986-990. PubMed ID: 33187793 [TBL] [Abstract][Full Text] [Related]